08048035968
Cancer SORANIB 200mg Tablet (1*120 Tab) trusted to Canada - Toronto | Phoenix Exim | Global Exporter

1. General Information

SORANIB 200mg Tablet contains sorafenib, an oral kinase inhibitor used in the treatment of certain cancers. Sorafenib is an established targeted cancer medicine indicated for unresectable hepatocellular carcinoma (liver cancer), advanced renal cell carcinoma (kidney cancer), and certain differentiated thyroid cancers that are refractory to radioactive iodine treatment.

SORANIB 200mg should be used only under the supervision of a qualified oncologist. It is a prescription medicine, and treatment decisions depend on the patient's cancer type, medical history, laboratory results, and response to therapy.

Phoenix Exim, Nagpur, India, deals in pharmaceutical products for international markets including the USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable import, prescription, and regulatory requirements.

2. Product Information

  • Product: SORANIB 200mg Tablet
  • Active ingredient: Sorafenib
  • Strength: 200mg per tablet
  • Dosage form: Film-coated oral tablet
  • Pack size: 1 × 120 tablets
  • Drug class: Kinase inhibitor / targeted anticancer medicine
  • Route: Oral
  • Prescription status: Prescription medicine

The reference sorafenib product is supplied as 200mg tablets, and bottles of 120 tablets are an established pack configuration.

3. Uses of SORANIB 200mg

Sorafenib is used for specific types of cancer, including:

  • Unresectable hepatocellular carcinoma (HCC), a type of liver cancer.
  • Advanced renal cell carcinoma (RCC), a type of kidney cancer.
  • Locally recurrent or metastatic differentiated thyroid carcinoma that is progressive and refractory to radioactive iodine treatment.

The exact indication and treatment plan must be determined by an oncologist.

4. Benefits of This Medicine

SORANIB 200mg may provide the following therapeutic benefits when appropriately prescribed:

  • Helps inhibit signaling pathways involved in cancer-cell growth.
  • Helps interfere with the formation of new blood vessels that tumors can use for growth.
  • May help slow cancer progression in approved indications.
  • Provides an oral targeted-treatment option for certain advanced cancers.

Sorafenib inhibits several intracellular and cell-surface kinases, including RAF, VEGFR, and PDGFR-related pathways involved in tumor signaling and angiogenesis.

Important: It is not appropriate to describe sorafenib as a guaranteed cure or to promise a specific treatment outcome.

5. Side Effects of SORANIB 200mg

Sorafenib can cause side effects, and their severity varies between patients. Important adverse effects can include:

  • Diarrhea
  • Fatigue
  • Hand-foot skin reaction
  • Skin rash
  • Hair loss
  • Loss of appetite
  • Weight loss
  • Nausea
  • Abdominal or gastrointestinal discomfort
  • High blood pressure
  • Bleeding or hemorrhage
  • Infection

Serious reactions can include cardiovascular events, significant bleeding, severe hypertension, serious skin reactions, liver injury, and other complications.

Patients should contact their healthcare professional promptly if they develop severe or unusual symptoms.

6. Common Side Effects

Commonly reported adverse reactions include:

  1. Diarrhea
  2. Fatigue
  3. Hand-foot skin reaction
  4. Rash
  5. Hair loss
  6. Decreased appetite
  7. Weight loss
  8. Nausea
  9. Abdominal or gastrointestinal pain
  10. Hypertension

These are among the adverse reactions reported at relatively high frequency in the prescribing information.

7. How to Use SORANIB 200mg

SORANIB 200mg should be taken exactly as prescribed by the treating oncologist.

For the reference sorafenib product, the labeled adult dosage is 400mg twice daily, equivalent to two 200mg tablets per dose, taken without food—at least 1 hour before or 2 hours after a meal. However, the appropriate dose may be modified or interrupted by the treating physician depending on tolerability, adverse reactions, liver/kidney function, other medicines, and the patient's clinical condition.

Do not change the dose, stop treatment, or restart treatment without medical advice.

8. How SORANIB 200mg Works

Sorafenib is a multikinase inhibitor. It acts on several signaling proteins involved in tumor-cell proliferation and angiogenesis.

By inhibiting pathways involving proteins such as BRAF, CRAF, VEGFR, PDGFR-β, KIT, FLT-3 and RET, sorafenib can interfere with signals that support cancer-cell growth and blood-vessel formation. This may help slow tumor growth and progression in cancers for which sorafenib is indicated.

9. Safety Advice for SORANIB 200mg

  • Use only under the supervision of an oncologist.
  • Tell your doctor about all medicines, supplements, and herbal products you take.
  • Blood pressure should be monitored, particularly during the early stages of treatment.
  • Report unusual or heavy bleeding immediately.
  • Inform your doctor about heart disease or previous cardiovascular problems.
  • Seek medical advice for severe skin reactions or significant hand-foot skin symptoms.
  • Liver-function monitoring may be required during treatment.
  • Sorafenib may cause fetal harm; appropriate pregnancy prevention and medical advice are important during treatment.
  • Breastfeeding is not recommended during treatment with the reference product.
  • Avoid grapefruit or other foods/products only if your treating healthcare professional advises avoidance based on your medication profile.
  • Store the medicine according to the product label; the reference product is stored at controlled room temperature in a dry place.

Seek urgent medical attention for symptoms such as chest pain, severe bleeding, severe allergic reactions, or other potentially serious symptoms.

10. Frequently Asked Questions (FAQs)

Q1. What is SORANIB 200mg Tablet?
SORANIB 200mg contains sorafenib, a targeted kinase inhibitor used for certain cancers.

Q2. What cancers can sorafenib treat?
Approved indications include unresectable hepatocellular carcinoma, advanced renal cell carcinoma, and certain progressive differentiated thyroid cancers that are refractory to radioactive iodine.

Q3. Is SORANIB 200mg a chemotherapy medicine?
Sorafenib is more specifically classified as a targeted kinase inhibitor rather than conventional cytotoxic chemotherapy.

Q4. Can I take SORANIB 200mg without a prescription?
No. It is a prescription anticancer medicine and should be used under specialist medical supervision.

Q5. Can the dose be changed if side effects occur?
The oncologist may interrupt or reduce treatment when clinically necessary. Patients should never change the dose independently.

Q6. What should I do if I miss a dose?
Follow the instructions provided by your treating doctor or pharmacist. Do not take extra tablets to compensate unless specifically instructed.

Q7. Can sorafenib cause high blood pressure?
Yes. Hypertension is a recognized adverse reaction, and blood-pressure monitoring is recommended.

Q8. Does SORANIB 200mg cure cancer?
Sorafenib is intended to control or treat specific cancers; it should not be promoted as a guaranteed cure. Treatment response varies between individuals.

Q9. Can SORANIB 200mg be taken during pregnancy?
Sorafenib may cause fetal harm. Patients who are pregnant, planning pregnancy, or could become pregnant should discuss appropriate precautions with their healthcare professional.

Q10. Is SORANIB 200mg the same as sorafenib?
SORANIB 200mg is a brand/product name associated with the active ingredient sorafenib 200mg. The exact manufacturer, formulation, and registration should be verified from the product packaging and regulatory documentation.

11. Substitute for SORANIB 200mg

A substitute should contain the same active ingredient and appropriate strength and should only be selected with the approval of the treating physician or pharmacist.

Possible sorafenib-based alternatives may include:

  • Sorafenib 200mg tablets from another approved manufacturer
  • Generic sorafenib 200mg tablets
  • Nexavar 200mg (sorafenib) – the reference branded product

However, a substitute should not be selected solely by brand name. Availability, regulatory approval, manufacturer, formulation, patient-specific factors, and physician preference should all be considered. The FDA/DailyMed labeling confirms Nexavar as a sorafenib 200mg tablet product.

12. SEO Keywords

  • SORANIB 200mg Tablet exporter from India
  • SORANIB 200mg Tablets supplier in India
  • SORANIB 200mg Tablet pharmaceutical exporter
  • SORANIB 200mg Tablet manufacturer and exporter
  • Sorafenib 200mg Tablet exporter from Nagpur India
  • Sorafenib 200mg Tablets supplier India
  • Sorafenib 200mg oncology medicine exporter
  • Sorafenib 200mg cancer medicine supplier
  • SORANIB 200mg Tablet international pharmaceutical supplier
  • Buy SORANIB 200mg Tablets from India
  • SORANIB 200mg Tablets export to USA
  • SORANIB 200mg Tablets export to UK
  • SORANIB 200mg Tablets export to Australia
  • SORANIB 200mg Tablets export to Singapore
  • SORANIB 200mg Tablets export to Canada
  • SORANIB 200mg Tablets export to South Korea
  • SORANIB 200mg Tablets export to UAE
  • Sorafenib 200mg supplier for international markets
  • Sorafenib 200mg targeted cancer medicine
  • Sorafenib 200mg tablets for liver cancer
  • Sorafenib 200mg tablets for kidney cancer
  • Sorafenib 200mg thyroid cancer medicine
  • SORANIB 200mg 120 tablets supplier
  • SORANIB 200mg 1×120 tablets exporter
  • Phoenix Exim pharmaceutical exporter Nagpur
  • Phoenix Exim sorafenib supplier India
  • Genuine SORANIB 200mg pharmaceutical supplier
  • SORANIB 200mg oncology tablets exporter India
  • Sorafenib 200mg wholesale pharmaceutical supplier
  • Sorafenib tablets international B2B supplier
Aug 21st, 2026 3:07 PM

Keywords